Skip to main content
. 2018 May 30;50(5):68. doi: 10.1038/s12276-018-0095-0

Table 2.

VTI-1002 in vivo safety data

Group information n Route of admin Treatment-related morbidity Adverse cutaneous drug reaction Mortality (no. of mice)
Exp. end-point Humane end-point Unexpected death
Vehicle 10 Topical 0 No observation of note 10 0 0
VTI-1002 18 Topical 0 No observation of note 18 0 0